Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hengtong Han

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Immunopharmacology|November 1, 2019
Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injuryHaitao Yu, Hengtong Han, Jiajia Li, et al.
The Review of Scientific Instruments|December 20, 2023
Predictive analysis of effects of water stress on strawberry seedlings using fluorescent image channel componentsBingqi Si, Min Jing, Ningchao Jiang, et al.
Biomolecules|September 27, 2025
The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune MicroenvironmentYating Zhang, Hengtong Han, Tingting Zhang, et al.
Molecular Cancer|October 7, 2025
Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodelingShouhua Li, Hengtong Han, Kaili Yang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 26, 2025
Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapyTingting Zhang, Hengtong Han, Tianying Zhang, et al.
Frontiers in Immunology|January 8, 2025
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implicationsXiaoxiao Li, Hengtong Han, Kaili Yang, et al.
International Immunopharmacology|November 27, 2024
Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancerShouhua Li, Hengtong Han, Kaili Yang, et al.
Cell Death Discovery|February 25, 2026
The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancerTianying Zhang, Hengtong Han, Yating Zhang, et al.
Cellular Signalling|November 7, 2025
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapyXiaoxiao Li, Hengtong Han, Shouhua Li, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|May 25, 2026
Prediction of Lymph Node Metastasis in Papillary Thyroid Cancer Using a Propensity Score-Matching-Based Platelet-to-HDL-C Ratio Plot Model: A Retrospective Cohort StudyTingting Zhang, Yating Zhang, Hengtong Han, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Immunopharmacology|November 1, 2019
Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injuryHaitao Yu, Hengtong Han, Jiajia Li, et al.
The Review of Scientific Instruments|December 20, 2023
Predictive analysis of effects of water stress on strawberry seedlings using fluorescent image channel componentsBingqi Si, Min Jing, Ningchao Jiang, et al.
Biomolecules|September 27, 2025
The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune MicroenvironmentYating Zhang, Hengtong Han, Tingting Zhang, et al.
Molecular Cancer|October 7, 2025
Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodelingShouhua Li, Hengtong Han, Kaili Yang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 26, 2025
Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapyTingting Zhang, Hengtong Han, Tianying Zhang, et al.
Frontiers in Immunology|January 8, 2025
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implicationsXiaoxiao Li, Hengtong Han, Kaili Yang, et al.
International Immunopharmacology|November 27, 2024
Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancerShouhua Li, Hengtong Han, Kaili Yang, et al.
Cell Death Discovery|February 25, 2026
The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancerTianying Zhang, Hengtong Han, Yating Zhang, et al.
Cellular Signalling|November 7, 2025
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapyXiaoxiao Li, Hengtong Han, Shouhua Li, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|May 25, 2026
Prediction of Lymph Node Metastasis in Papillary Thyroid Cancer Using a Propensity Score-Matching-Based Platelet-to-HDL-C Ratio Plot Model: A Retrospective Cohort StudyTingting Zhang, Yating Zhang, Hengtong Han, et al.
Pageof 1